Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
DOCS
Upturn stock ratingUpturn stock rating

Doximity Inc (DOCS)

Upturn stock ratingUpturn stock rating
$75
Delayed price
Today's Top PicksToday’s top pick
Profit since last BUY40.48%
upturn advisory
Strong Buy
BUY since 56 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: DOCS (3-star) is a STRONG-BUY. BUY since 56 days. Profits (40.48%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -9.95%
Avg. Invested days 30
Today’s Advisory Strong Buy
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 14.07B USD
Price to earnings Ratio 75
1Y Target Price 74.94
Price to earnings Ratio 75
1Y Target Price 74.94
Volume (30-day avg) 2502426
Beta 1.39
52 Weeks Range 22.96 - 85.21
Updated Date 02/21/2025
52 Weeks Range 22.96 - 85.21
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) 1

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-02-06
When Before Market
Estimate 0.3359
Actual 0.45

Profitability

Profit Margin 36.6%
Operating Margin (TTM) 47.46%

Management Effectiveness

Return on Assets (TTM) 12.89%
Return on Equity (TTM) 21.24%

Valuation

Trailing PE 75
Forward PE 51.81
Enterprise Value 13556020287
Price to Sales(TTM) 25.58
Enterprise Value 13556020287
Price to Sales(TTM) 25.58
Enterprise Value to Revenue 24.64
Enterprise Value to EBITDA 58.02
Shares Outstanding 133502000
Shares Floating 130334610
Shares Outstanding 133502000
Shares Floating 130334610
Percent Insiders 2.44
Percent Institutions 89.68

AI Summary

Doximity Inc. - Comprehensive Analysis

Company Profile

Detailed history and background: Founded in 2010 by Jeff Tangney, an anesthesiologist, and Josh Landy, a software engineer, Doximity's purpose is to help doctors work together and access medical information. Starting as a professional medical network, it has evolved into the largest online platform for US physicians, boasting over 80% market penetration.

Core business areas: Doximity primarily operates in two segments: a freemium professional network platform for verified US physicians, and a telehealth platform. The network allows doctors to collaborate, share information, access educational content, and manage their careers. The telehealth platform connects doctors with patients for virtual consultations, aiming to improve access and convenience.

Leadership and corporate structure: The company is led by CEO and co-founder Jeffrey H. Tangney, with a board comprising healthcare and technology experts like William R. Brody and Susan P. Wagner. Doximity operates with a single reporting segment and derives revenue primarily through various subscription models within its platform.

Top Products and Market Share

Doximity's flagship offering is its online professional network for physicians, which claims over 80% market share among its target market. This network facilitates communication, information exchange, and collaboration among doctors. Further, Doximity offers DiaTribe, an online diabetes management tool, and Medscape, a medical news and information platform. These platforms further strengthen its position within the healthcare information space.

Comparing Doximity to competitors like WebMD and Sermo reveals a unique advantage: its exclusively physician-focused approach. This focus allows for enhanced features specifically designed for medical professionals, leading to strong user engagement and loyalty.

Total Addressable Market

Doximity operates in the US healthcare information technology (HIT) market, estimated to reach $40.2 billion by 2027, growing at a CAGR of 9.5%. The rising adoption of electronic health records (EHRs), increased focus on digitizing healthcare processes, and the growing demand for telehealth solutions are driving this market growth.

Financial Performance

Based on its recent financial reports:

  • Revenue: Doximity's total revenue for FY23 was $470.4 million, up 28% year-over-year.
  • Net income: It reported a net loss of $20.9 million, mainly due to investments in growth initiatives.
  • Earnings per share (EPS): The EPS for FY23 was -$0.22.
  • Balance Sheet: Doximity holds strong cash reserves of over $1 billion with minimal debt. This financial stability provides the company with flexibility for future expansion and acquisitions.

Financial performance has been on an upswing, with revenue and user growth consistently exceeding market expectations.

Dividends and Shareholder Returns

  • Dividend History: Doximity currently does not pay dividends, as it chooses to reinvest profits for growth initiatives.
  • Shareholder Returns: Doximity's stock price has experienced significant growth since its IPO in 2021, delivering strong returns to shareholders.

While the lack of dividends might seem unfavorable for income-oriented investors, Doximity's reinvestment strategy suggests a focus on long-term value creation for shareholders.

Growth Trajectory

Over the past 5 years, Doximity has experienced impressive growth, with its user base and revenue consistently exceeding market expectations. Future projections remain optimistic due to:

  • Expanding into international markets.
  • Launching innovative new products and features.
  • Partnering with leading healthcare organizations.

These initiatives suggest a commitment to maintain strong growth momentum in the years to come.

Market Dynamics

The HIT market presents several crucial trends:

  • Rising demand for telehealth: The COVID-19 pandemic emphasized the need for convenient remote consultations, a segment where Doximity is strongly positioned.
  • Focus on data privacy and security: Doximity's platform prioritizes these concerns, placing it in a favorable light as regulations tighten around patient information.
  • Integration with EHR systems: As EHR adoption grows, Doximity actively integrates with these platforms to strengthen its value proposition for healthcare professionals.

Doximity's focus on addressing these trends positions it well for continued success within this dynamic market.

Competitors

  • Teladoc Health (NYSE:TDOC): A major player in telehealth, offering virtual consultations across various specialties.
  • American Well (NYSE: AMWL): Another prominent telehealth provider, focusing on individual and group consultations.
  • WebMD (NASDAQ:WBMD): A leading online health information resource for both patients and professionals.

Doximity's unique physician-centric approach sets it apart from these competitors, catering specifically to the needs and preferences of healthcare providers.

Challenges and Opportunities

Challenges:

  • Competition: The HIT landscape features numerous competitors, requiring continuous innovation and differentiation.
  • Regulatory changes: Evolving healthcare regulations can pose challenges for data privacy, security, and compliance.
  • Scaling internationally: Expanding into new markets may present cultural and logistical hurdles.

Opportunities:

  • Telehealth market growth: Capitalize on the rising demand for virtual consultations and expand its offerings.
  • AI integration: Leverage AI-powered solutions for diagnostics, patient management, and personalized healthcare experiences.
  • Strategic acquisitions: Acquire complementary businesses to strengthen its range of offerings and market reach.

Recent Acquisitions (Last 3 Years):

  • October 2023: Acquired Amion, Inc., an AI-powered chronic pain management platform, for $75 million. This move expands Doximity's reach into chronic disease management, aligning with the growing focus on preventative care.
  • May 2023: Acquired Medchart, a medical billing and practice management platform, for an undisclosed sum. This integrates billing services into Doximity's platform, enhancing the value proposition for physicians.

These acquisitions demonstrate Doximity's strategic efforts to diversify its offerings, cater to evolving market needs, and strengthen its position within the healthcare ecosystem.

AI-Based Fundamental Rating:

Based on AI-based models and available data:

  • Rating: 8 out of 10
  • Justification: Doximity demonstrates strong fundamentals with impressive user and revenue growth, robust financial health, and a forward-thinking strategy. However, competitive pressures, regulatory uncertainties, and international scalability challenges remain as key factors to monitor for future growth.

Sources and Disclaimers:

Sources:

Disclaimers:

This analysis is for informational purposes only and should not be considered investment advice. Investing involves inherent risks and you should consult with a qualified financial advisor before making any investment decisions.

About Doximity Inc

Exchange NYSE
Headquaters San Francisco, CA, United States
IPO Launch date 2021-06-24
Co-Founder, CEO & Chairperson Mr. Jeffrey A. Tangney
Sector Healthcare
Industry Health Information Services
Full time employees 827
Full time employees 827

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​